Marshall Wace’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.15M Buy
31,200
+6,075
+24% +$419K ﹤0.01% 1412
2025
Q1
$1.74M Sell
25,125
-1,142,373
-98% -$79.3M ﹤0.01% 1431
2024
Q4
$100M Buy
1,167,498
+986,195
+544% +$84.8M 0.12% 144
2024
Q3
$21.6M Sell
181,303
-510,138
-74% -$60.7M 0.03% 442
2024
Q2
$98.7M Buy
691,441
+689,441
+34,472% +$98.4M 0.13% 132
2024
Q1
$257K Sell
2,000
-231,879
-99% -$29.8M ﹤0.01% 1897
2023
Q4
$24.2M Buy
+233,879
New +$24.2M 0.04% 363
2023
Q3
Sell
-227,832
Closed -$18.4M 2175
2023
Q2
$18.4M Buy
227,832
+164,320
+259% +$13.3M 0.04% 445
2023
Q1
$5.05M Buy
+63,512
New +$5.05M 0.01% 845
2022
Q4
Sell
-23,184
Closed -$1.16M 2666
2022
Q3
$1.16M Buy
+23,184
New +$1.16M ﹤0.01% 1750
2022
Q2
Sell
-7,332
Closed -$407K 3014
2022
Q1
$407K Sell
7,332
-1,746
-19% -$96.9K ﹤0.01% 2178
2021
Q4
$508K Sell
9,078
-17,366
-66% -$972K ﹤0.01% 2155
2021
Q3
$1.27M Buy
+26,444
New +$1.27M 0.01% 1441
2021
Q1
Sell
-33,246
Closed -$1.16M 2398
2020
Q4
$1.16M Sell
33,246
-61,236
-65% -$2.14M 0.01% 1038
2020
Q3
$3.28M Buy
+94,482
New +$3.28M 0.02% 632
2020
Q2
Sell
-1,626
Closed -$49K 1804
2020
Q1
$49K Buy
+1,626
New +$49K ﹤0.01% 1425
2017
Q1
Sell
-793,448
Closed -$14.2M 612
2016
Q4
$14.2M Buy
793,448
+436,840
+122% +$7.83M 0.09% 253
2016
Q3
$7.42M Buy
+356,608
New +$7.42M 0.05% 329
2015
Q4
Sell
-68,646
Closed -$1.86M 1078
2015
Q3
$1.86M Buy
+68,646
New +$1.86M 0.02% 470